Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Clinical trial NCT01438775 · COMPLETED
Trial details
- NCT number
- NCT01438775
- Sponsor
- Nymox Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-01-01
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.